Nuvectis Pharma Inc is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NVCT is expected to report earnings to fall 42.27% to -25 cents per share on March 10
Q4'25
Est.
$-0.25
Q3'25
Missed
by $0.19
Q2'25
Missed
by $0.05
Q1'25
Beat
by $0.53
Q4'24
Missed
by $0.09
The last earnings report on November 04 showed earnings per share of -43 cents, missing the estimate of -25 cents. With 122.07K shares outstanding, the current market capitalization sits at 152.92M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NVCT showed earnings on November 04, 2025. You can read more about the earnings report here.